SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-16-017884
Filing Date
2016-11-15
Accepted
2016-11-15 07:25:53
Documents
18
Period of Report
2016-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp70289_6k.htm 6-K 27675
2 EXHIBIT 99.1 dp70289_ex9901.htm EX-99.1 21742
3 GRAPHIC image_001.jpg GRAPHIC 288709
4 GRAPHIC image_002.jpg GRAPHIC 128128
5 GRAPHIC image_003.jpg GRAPHIC 176132
6 GRAPHIC image_004.jpg GRAPHIC 184666
7 GRAPHIC image_005.jpg GRAPHIC 175961
8 GRAPHIC image_006.jpg GRAPHIC 243934
9 GRAPHIC image_007.jpg GRAPHIC 177410
10 GRAPHIC image_008.jpg GRAPHIC 213581
11 GRAPHIC image_009.jpg GRAPHIC 227120
12 GRAPHIC image_010.jpg GRAPHIC 163518
13 GRAPHIC image_011.jpg GRAPHIC 153461
14 GRAPHIC image_012.jpg GRAPHIC 134484
15 GRAPHIC image_013.jpg GRAPHIC 269717
16 GRAPHIC image_014.jpg GRAPHIC 123615
17 GRAPHIC image_015.jpg GRAPHIC 97996
18 GRAPHIC image_016.jpg GRAPHIC 122234
  Complete submission text file 0000950103-16-017884.txt   4019918
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 161997822
SIC: 2834 Pharmaceutical Preparations